Company: BIAF
Filing Date: 2025-05-27
Form Type: 424B5
Source: 0001641172-25-012410
Chunk: 79

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 424B5
Chunk 79
---
 Bylaws could make a merger, tender offer, or proxy contest difficult, thereby depressing the trading price of our Common Stock.

Our Charter and A&R Bylaws contain provisions that could depress the trading price of our Common Stock by acting to discourage, delay or prevent a change of control of our Company or changes in our management that the stockholders of our Company may deem advantageous. These provisions include the following:

| ● | permit                                                                                                                             
 the Board of Directors to establish the number of directors and fill any vacancies and newly-created directorships;                |
| ● | authorize                                                                                                                          
 the issuance of “blank check” preferred stock that our Board of Directors could use to implement a stockholder rights              
 plan;                                                                                                                              |
| ● | prohibit                                                                                                                           
 stockholders from calling special meetings of stockholders;                                                                        |
| ● | prohibit                                                                                                                           
 stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;        |
| ● | provide                                                                                                                            
 that the Board of Directors is expressly authorized to adopt, amend, alter or repeal our bylaws;                                   |
| ● | restrict                                                                                                                           
 the forum for certain litigation against us to Delaware; and                                                                       |
| ● | establish                                                                                                                          
 advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted upon 
 by stockholders at annual stockholder meetings.                                                                                    |

| 28 |

Any provision in our Charter or A&R Bylaws that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our Common Stock and could also affect the price that some investors are willing to pay for our Common Stock.

Certain provisions of the DGCL may have anti-takeover effects that could delay, defer, or discourage another party from acquiring control of us, prevent changes in our Board of Directors or management, and make certain transactions more challenging that stockholders might otherwise believe to be in their best interests.

We are subject to the provisions of Section 203 of the DGCL, which generally prohibits us from engaging in a “business combination,” meaning a merger, asset sale, or other transaction resulting in a stockholder’s financial benefit, with an “interested stockholder” for a three-year period following the time that such stockholder becomes an interested stockholder, unless the business combination is approved in a manner prescribed by Section 203. Section 203 defines an “interested stockholder” as a person who, together with affiliates